Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cancer Stem Cells

Cancer Stem Cells SANTA MONICA SUPPLEMENT Summary of Presentations from the Ninth Annual Targeted Therapies in Lung Cancer Symposium Ramaswamy Govindan, MD ver the past several years, leading experts from around the world have been gathering Oannually in Santa Monica, CA, to discuss strategies for improving the outcomes of patients with lung cancer using molecularly targeted therapies. In contrast to the annual meeting of the American Society of Clinical Oncology or American Association of Cancer Research, this is a large “work in progress” meeting. As we are beginning to unravel the bewildering and complex network of dysregulated pathways in cancer in lung cancer, annual conferences similar to the one held in Santa Monica have become indispensable to generate novel ideas and exchange valuable experience gleaned from ongoing studies. A formidable number of agents, summarized by Drs. George Simon and Neeta Somaiah, are being studied in lung cancer today. Keeping up with the constant flow of new information is a challenge even for the very committed student of lung cancer. As the attendance is limited (and by invitation only), we feel that the larger thoracic oncology community would benefit from an enduring material from the “Santa Monica Meeting.” The contributors were asked to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Cancer Stem Cells

Minna, John
Journal of Thoracic Oncology , Volume 4 – Nov 1, 2009
Download PDF
45 pages

Loading next page...
 
/lp/wolters-kluwer-health/cancer-stem-cells-kkJA3x8Yxx

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864

Abstract

SANTA MONICA SUPPLEMENT Summary of Presentations from the Ninth Annual Targeted Therapies in Lung Cancer Symposium Ramaswamy Govindan, MD ver the past several years, leading experts from around the world have been gathering Oannually in Santa Monica, CA, to discuss strategies for improving the outcomes of patients with lung cancer using molecularly targeted therapies. In contrast to the annual meeting of the American Society of Clinical Oncology or American Association of Cancer Research, this is a large “work in progress” meeting. As we are beginning to unravel the bewildering and complex network of dysregulated pathways in cancer in lung cancer, annual conferences similar to the one held in Santa Monica have become indispensable to generate novel ideas and exchange valuable experience gleaned from ongoing studies. A formidable number of agents, summarized by Drs. George Simon and Neeta Somaiah, are being studied in lung cancer today. Keeping up with the constant flow of new information is a challenge even for the very committed student of lung cancer. As the attendance is limited (and by invitation only), we feel that the larger thoracic oncology community would benefit from an enduring material from the “Santa Monica Meeting.” The contributors were asked to

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Nov 1, 2009

There are no references for this article.